Diabetes supply payments
This article was originally published in The Gray Sheet
Executive Summary
NHIC, Medicare's durable medical equipment administrative contractor for the northeast U.S., paid about $39.2 million in inappropriate claims for home blood glucose test strips and lancets in 2007, according to a recent 1analysis by the Health and Human Services Office of Inspector General. OIG recommends that NHIC implement better checks to identify high-utilization claims and those with overlapping service dates, and work with CMS to develop better systems to identify test strip and lancet claims most in need of extra review
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.